Friedman Capital has appointed Randolph Friedman as a managing partner, Citybizlist reports. Friedman will lead the launch of the firm’s direct private equity investment strategy.
Previously, Friedman was the Chairman and CEO of Harvard Drug Group. Friedman Capital will invest the personal capital of the Friedman family and offer co-investment opportunities to a select group of high-net-worth and institutional investors for larger deals.
Click here for the story from Citybizlist.